Cryo-Cell
CCEL
#10014
Rank
โ‚ฌ27.59 M
Marketcap
3,43ย โ‚ฌ
Share price
1.01%
Change (1 day)
-56.75%
Change (1 year)
Categories

P/E ratio for Cryo-Cell (CCEL)

P/E ratio as of December 2025 (TTM): 14.1

According to Cryo-Cell's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.0714. At the end of 2024 the company had a P/E ratio of 163.

P/E ratio history for Cryo-Cell from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024163-4202.27%
2023-3.98-131.49%
202212.6-66.86%
202138.1204%
202012.5-39.98%
201920.9-142.18%
2018-49.5-356.23%
201719.3-189.64%
2016-21.6-792.23%
20153.11-93.07%
201444.9-92.36%
2013588-16064.86%
2012-3.68-51.12%
2011-7.53-223.76%
20106.08-50.79%
200912.4-310.23%
2008-5.88135.32%
2007-2.50-68.97%
2006-8.05-125.67%
200531.4283.44%
20048.18-911.08%
2003-1.01-63.78%
2002-2.78-104.96%
200156.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
CorVel Corporation
CRVL
33.9 141.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Global Cord Blood
CORBF
1.48-89.50%๐Ÿ‡ญ๐Ÿ‡ฐ Hong Kong
Omnicell
OMCL
94.4 570.67%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.